Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358917
Status:
COMPLETED
Last Update Posted:
2011-04-11
First Post:
2006-07-28
Brief Title:
Study of LopinavirRitonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With NucleosideNucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects
Sponsor:
Abbott
Organization:
Abbott
Organization Data
Organization:
Abbott
Class:
INDUSTRY
Study ID:
M06-802
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Abbott
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Barry Bernstein MD Project Director
Old Organization:
Abbott